Sponsor pipeline

ImmuneOncia Therapeutics Inc. clinical trial pipeline

Get alerts when ImmuneOncia Therapeutics Inc.'s trials change

3 active trials 2 recruiting

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

Active trials by phase

Phase 1
1
Phase 2
2

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2
NCT06365840 A Study of IMC-001 In Patients With Metastatic Or Locally Advanced TMB-H Solid Tumor TMB-H Recruiting 2026-04-17
NCT04414163 A Study of IMC-001 in Subjects With Relapsed or Refractory Extranodal NK/T Cell Lymphoma… Extranodal NK/T-cell Lymphoma, Nasal Type Active, Not Recruiting 2026-04-24
Phase 1
NCT05276310 A Study of IMC-002 in Patients With Advanced Cancer Failed to Standard Therapy Advanced Cancer Recruiting 2026-04-24
Get alerts when ImmuneOncia Therapeutics Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free